Fluvoxamine ER Uses, Dosage, Side Effects and more
| Attribute | Details |
|---|---|
| Trade Name | Fluvoxamine ER |
| Generic | 2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one |
| Type | Capsule, extended release |
| Formula | C8H10N2OS |
| Weight | Average: 182.243 Monoisotopic: 182.051383642 |
| Groups | Experimental |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | United States |
| Last Updated: | January 7, 2025 at 1:49 am |
